Wire Stories
Eucure Biopharma, a Subsidiary of Biocytogen Pharmaceuticals, Licenses OX40 Antibody (YH002) and Multiple Active Ingredients to Syncromune for the Development and Commercialization of Intratumoral Immunotherapy
BEIJING, China & FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–#Biocytogen–Eucure (Beijing) Biopharma Co., Ltd. (�Eucure�), a wholly owned subsidiary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd....